Abdominal pain, a common complaint in clinical practice, presents a diagnostic challenge due to its broad differential diagnoses. This article aims to provide a comprehensive approach to evaluating such cases, enhancing diagnostic accuracy and patient management.
Initial assessment should focus on identifying 'red flags' suggestive of serious pathology. A detailed history, encompassing the nature, location, onset, duration, and associated symptoms of the pain, is crucial. Special attention should be given to factors that exacerbate or alleviate the pain, as well as any relevant past medical or surgical history.
Physical examination should be systematic, starting with inspection and palpation, followed by auscultation and percussion. The presence of scars, distension, or visible peristalsis provides valuable clues. Tenderness, guarding, or rigidity may indicate underlying pathology, while specific signs can suggest certain diagnoses.
Basic laboratory tests, including complete blood count, liver and renal function tests, and inflammatory markers, can guide further investigations. Imaging studies, such as ultrasound or computed tomography, are often necessary to confirm the diagnosis. More specialized tests, like endoscopy or colonoscopy, may be required based on clinical suspicion.
Management should be tailored to the underlying cause. Analgesia, while often necessary, should not compromise the clinical assessment. Patients with non-specific abdominal pain may require reassessment or further investigations if symptoms persist. A clear follow-up plan is essential to ensure appropriate care.
Abdominal pain evaluation requires a methodical approach, incorporating a thorough history, physical examination, and judicious use of investigations. Recognizing 'red flags', understanding the limitations of physical findings and investigations, and tailoring management to the individual patient are key to successful outcomes in this challenging area of clinical practice.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation